US Patent 7888102 Cell line for producing coronaviruses
Patent 7888102 was granted and assigned to Crucell on February, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+201 characters)
Article
Patent abstract
The invention relates to the production of coronaviruses. In particular, the invention relates to methods for producing SARS-CoV by using cells expressing a functional SARS-CoV receptor.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Edward Norbert Van Den Brink0
Jan Henrik Ter Meulen0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07888102 Cell line for producing coronaviruses US Patent 7888102 Cell line for producing coronaviruses
Infobox
Patent Number
078881020
Patent Number
78881020
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078881020
Date of Patent
February 15, 2011
0Patent Application Number
119881460
Date Filed
July 21, 2006
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07888102 Cell line for producing coronaviruses
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07888102
Date of patent
February 15, 2011
Patent application number
11988146
Date Filed
July 21, 2006
Patent primary examiner
Find more entities like US Patent 7888102 Cell line for producing coronaviruses
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.